MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2025 International Congress

    Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected

    J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

    Objective: To describe incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with cervical dystonia (CD) Background: IncobotulinumtoxinA is approved to treat CD…
  • 2025 International Congress

    Blepharospasm as cause of facial pain and “sinus” headache: A case series

    J. Anang (Winnipeg, Canada)

    Objective: Describe the clinical spectrum of blepharospasm Background: Blepharospasm is characterized by stereotyped, bilateral and synchronous spasms of the orbicularis oculi muscles Method: Case report…
  • 2025 International Congress

    Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

    K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)

    Objective: To evaluate the potential benefits of a post-injection telehealth follow-up visit for people with craniofacial dystonia. Background: Craniofacial dystonias, including blepharospasm and oromandibular dystonia,…
  • 2025 International Congress

    Delayed Diagnosis of Cervical Dystonia: A Case Report Highlighting the Importance of an on-time Specialist Evaluation

    A. Lysandropoulos (Durham, USA)

    Objective: To present a case of cervical dystonia misdiagnosed as anxiety disorder for five years, emphasizing the critical need for timely recognition and appropriate treatment…
  • 2025 International Congress

    Dystonia in Cameroon: Clinical characteristic and treatment patterns

    HD. Ewodo Touna, D. Gams Massi, M A. Magnerou, C. Kenmegne, E. Chokote, E. Gueumekane Bila, M. Tonga, D. Atsa Kouda, G. Nokam, Y. Mapoure Njankouo (Douala, Cameroon)

    Objective: To describe the clinical characteristics and treatment patterns of dystonia in a cohort of Cameroonian patients. Background: Dystonia is a complex and heterogeneous movement…
  • 2025 International Congress

    Pontine Hemorrhage leading to Bilateral Olivary Degeneration and Cervical Dystonia

    M. Iqbal, C. Tarolli, D. Manou (Rochester, USA)

    Objective: We describe a case of a 66-year-old woman who developed cervical dystonia with dystonic tremor and hypertrophic olivary degeneration (HOD) after a right pontine…
  • 2025 International Congress

    Pilot Study: Shear Wave Elastography as a Potential Biomarker in Task-Specific Dystonia

    A. Ly, A. Mushtaheed, A. Roberts, M. Druckenbrod, J. Stowers, M. Soliman, P. Lind, Y. Assefa, C. Stanley, A. Gravunder, J. Matsubara, C. Zampieri-Gallagher, D. Ehrlich, B. Karp, F. Gavelli, K. Alter (Bethesda, USA)

    Objective: The purpose of this study was to explore shear wave elastography (SWE)’s ability to identify task-specific dystonic muscles by determining if muscle stiffness increased…
  • 2025 International Congress

    Comparative Effectiveness of Botulinum Toxin vs. Oral Medications in the Management of Cervical Dystonia: A Multi-Center Study

    A. Chandra, A. Chandra, S. Acharya (Tianjin, China)

    Objective: This study aims to compare the effectiveness of botulinum toxin injections versus oral medications in the symptomatic management of cervical dystonia , evaluating their…
  • 2025 International Congress

    Physician Assessment of Non-Medical Toxin Switching on Patient Care

    P. Charles, L. Venditti, M. Nelson, R. Singh, K. Pazira, H. Kling, L. Kopaeva, S. Sharp, K. Harper (Nashville, USA)

    Objective: To gain an understanding from physicians on the impact of non-medical toxin switching (NMTS) in the treatment of movement disorders and other chronic conditions…
  • 2025 International Congress

    Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia

    M. Relja, D. Dressler, F. Morgante, V. Trjulja (Zagreb, Croatia)

    Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A  (BoNT-A) in cervical dystonia (CD) using patient s on-line survey. Background: CD…
  • 1
  • 2
  • 3
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley